ALX Oncology | 4: Statement of changes in beneficial ownership of securities-Director Hemrajani Rekha
ALX Oncology | 4: Statement of changes in beneficial ownership of securities-Director Garland J. Scott
ALX Oncology | 4: Statement of changes in beneficial ownership of securities-Director GOODMAN COREY S
ALX Oncology | 4: Statement of changes in beneficial ownership of securities-Director Takimoto Chris H
ALX Oncology | 3: Initial statement of beneficial ownership of securities-Director Takimoto Chris H
ALX Oncology | 4: Statement of changes in beneficial ownership of securities-Director Klencke Barbara
ALX Oncology | 3: Initial statement of beneficial ownership of securities-Director Klencke Barbara
ALX Oncology | 4: Statement of changes in beneficial ownership of securities-Officer Shantharam Harish
ALX Oncology | 3: Initial statement of beneficial ownership of securities-Officer Shantharam Harish
ALX Oncology | 4: Statement of changes in beneficial ownership of securities-Officer Pinto Shelly
ALX Oncology | 4: Statement of changes in beneficial ownership of securities-Officer Sandler Alan B.
ALX Oncology | 4: Statement of changes in beneficial ownership of securities-Officer Pons Jaume
ALX Oncology | 4: Statement of changes in beneficial ownership of securities-Officer Lettmann Jason
ALX Oncology | 8-K: Current report
ALX Oncology | 8-K: Current report
ALX Oncology | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
ALX Oncology | 4: Statement of changes in beneficial ownership of securities-Officer Pinto Shelly
ALX Oncology | 4: Statement of changes in beneficial ownership of securities-Officer Pinto Shelly
ALX Oncology | 4: Statement of changes in beneficial ownership of securities-Officer Pons Jaume
ALX Oncology | SC TO-I/A: Third party tender offer statement (Amendment)